Welcome to BC PharmaCare's public survey of drugs being reviewed for coverage. This survey is for spesolimab (Spevigo) for treatment of generalized pustular psoriasis (GPP), including treatment and prevention of flares, in adults and pediatric patients 12 years of age and older.